Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Health Technology Assessment (Winchester, England)
|
March 1, 2017
Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
Hema Mistry, Martin Connock, Joshua Pink, et al.
The Cochrane Database of Systematic Reviews
|
August 25, 2017
Whole grain cereals for the primary or secondary prevention of cardiovascular disease
Sarah Am Kelly, Louise Hartley, Emma Loveman, et al.
Health Technology Assessment (Winchester, England)
|
March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
Rhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)
|
January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
Rhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Health Technology Assessment (Winchester, England)
|
March 1, 2017
Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
Hema Mistry, Martin Connock, Joshua Pink, et al.
The Cochrane Database of Systematic Reviews
|
August 25, 2017
Whole grain cereals for the primary or secondary prevention of cardiovascular disease
Sarah Am Kelly, Louise Hartley, Emma Loveman, et al.
Health Technology Assessment (Winchester, England)
|
March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
Rhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)
|
January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
Rhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Page
of 3